Insight Molecular Diagnostics Inc.

IMDX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$61-$28-$73-$64
Dep. & Amort.$2$2$5$4
Deferred Tax$0$0$0-$9
Stock-Based Comp.$2$7$10$7
Change in WC-$1-$4-$2$0
Other Non-Cash$38$0$14$26
Operating Cash Flow-$21-$23-$46-$36
Investing Activities
PP&E Inv.-$1-$0-$4-$2
Net Acquisitions$0$0$0-$12
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$1$0$0
Investing Cash Flow-$1-$1-$4-$14
Financing Activities
Debt Repay.-$0-$0-$1-$2
Stock Issued$28$14$33$78
Stock Repurch.$0$0$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$7-$2$4$2
Financing Cash Flow$20$12$36$78
Forex Effect$0$0$0$0
Net Chg. in Cash-$1-$12-$14$28
Supplemental Information
Beg. Cash$11$23$37$9
End Cash$10$11$23$37
Free Cash Flow-$21-$24-$50-$38